Mometasone Furoate Solution
NDC 72162-1392
Product Information
Mometasone Furoate is a ANDA-approved product labeled by Bryant Ranch Prepack. This medication is used to treat skin conditions such as eczema, psoriasis, allergies, and rash. It is supplied as a solution for topical administration. This product entry covers the primary NDC 72162-1392 and 2 associated package configurations. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Clinical Specifications
Labeler & Regulatory Data
Marketing Timeline
Code Structure Chart
Product Details
What is NDC 72162-1392?
What are the uses of this product?
What are Active Ingredients of this product?
- MOMETASONE FUROATE 1 mg/mL - A pregnadienediol derivative ANTI-ALLERGIC AGENT and ANTI-INFLAMMATORY AGENT that is used in the management of ASTHMA and ALLERGIC RHINITIS. It is also used as a topical treatment for skin disorders.
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- MOMETASONE FUROATE (UNII: 04201GDN4R)
- MOMETASONE (UNII: 8HR4QJ6DW8) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- ISOPROPYL ALCOHOL (UNII: ND2M416302)
- HEXYLENE GLYCOL (UNII: KEH0A3F75J)
- SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS (UNII: KH7I04HPUU)
- WATER (UNII: 059QF0KO0R)
- GLYCERIN (UNII: PDC6A3C0OX)
- OLEIC ACID (UNII: 2UMI9U37CP)
- PHOSPHORIC ACID (UNII: E4GA8884NN)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 151030 - mometasone furoate 0.1 % Topical Solution (Lotion)
- RxCUI: 151030 - mometasone furoate 1 MG/ML Topical Lotion
- RxCUI: 151030 - mometasone furoate 0.1 % Topical Lotion
Which are the Pharmacologic Classes of this product?
* Please review the full disclaimer at the bottom of this page.